Company

Atro Medical

Wear and damage of the meniscus is an important cause of osteoarthritis in the knee, which causes joint pain and a reduction of mobility. Trammpolin™ has been developed for replacing the damaged meniscus with a minimally invasive surgical procedure and with that reducing the pain of the patient. An additional benefit would be that a total knee replacement can be postponed by several years. Trammpolin™, made of an elastic polymer, is the first total meniscus replacement in the world that has an anatomical shape.

Pre-clinical research, including mechanical tests and an animal study with goats, have been completed and have yielded promising results. At the moment, ATRO Medical is working hard on the transition to the clinic and the first implantation of a Trammpolin™ meniscus prosthesis in the patient is expected in 2020.

Atro Medical

Transistorweg 5 (Building M)

6534 AT Nijmegen

The Netherlands

Website

More companies in this area

Staten Biotechnology

Staten Biotechnology aims to develop novel and innovative strategies for the prevention of cardiovascular events, the largest unmet medical need in dyslipidemia.

SPL Medical

SPL Medical is strongly committed to improve MRI imaging to enable a much more precise, effective and patient friendly diagnosis of cancer metastasis.

QM Diagnostics

QM Diagnostics is an internationally operating, independent and innovative diagnostic microbiological laboratory.

We are specialized in health monitoring of small laboratory animals used for biomedical research.

Cardiacbooster

Developing the next generation of percutaneous left ventricular assist devices.

Enzyre

Enzyre will enable personalized diagnostics by developing disposable biochips measuring, in one drop of blood, multiple parameters of specific interest to each patient group, with higher accuracy and at lower costs.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!